BG61040B1 - Метод за получаване на пречистени лизозимни димери - Google Patents

Метод за получаване на пречистени лизозимни димери Download PDF

Info

Publication number
BG61040B1
BG61040B1 BG96578A BG9657892A BG61040B1 BG 61040 B1 BG61040 B1 BG 61040B1 BG 96578 A BG96578 A BG 96578A BG 9657892 A BG9657892 A BG 9657892A BG 61040 B1 BG61040 B1 BG 61040B1
Authority
BG
Bulgaria
Prior art keywords
lysozyme
solution
dimer
elution
dimerization
Prior art date
Application number
BG96578A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG96578A (bg
Inventor
Peter Herrmann
Peter Klein
Original Assignee
Nika Health Products Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nika Health Products Ltd filed Critical Nika Health Products Ltd
Publication of BG96578A publication Critical patent/BG96578A/bg
Publication of BG61040B1 publication Critical patent/BG61040B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
BG96578A 1990-01-08 1992-07-07 Метод за получаване на пречистени лизозимни димери BG61040B1 (bg)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
SG1996007945A SG49871A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
CA002073351A CA2073351C (en) 1990-01-08 1990-01-08 Lysozyme dimers and method of preparing them
PCT/US1990/000140 WO1991010731A1 (en) 1990-01-08 1990-01-08 Method of preparing lysozyme dimers
HU9202250A HU214509B (hu) 1990-01-08 1990-01-08 Eljárás tisztított lizozim dimerek előállítására
RO92-0931A RO114805B1 (ro) 1990-01-08 1990-01-08 Dimer de lizozim purificat si procedeu de obtinere a acestuia
OA60242A OA09706A (en) 1990-01-08 1992-07-07 Method of preparing lysozyme dimers.

Publications (2)

Publication Number Publication Date
BG96578A BG96578A (bg) 1993-12-24
BG61040B1 true BG61040B1 (bg) 1996-09-30

Family

ID=33136306

Family Applications (1)

Application Number Title Priority Date Filing Date
BG96578A BG61040B1 (bg) 1990-01-08 1992-07-07 Метод за получаване на пречистени лизозимни димери

Country Status (21)

Country Link
EP (1) EP0509984B1 (lt)
JP (1) JP2732514B2 (lt)
KR (1) KR0158216B1 (lt)
AU (1) AU654651B2 (lt)
BG (1) BG61040B1 (lt)
BR (1) BR9007971A (lt)
CA (1) CA2073351C (lt)
DE (1) DE69032375T2 (lt)
DK (1) DK0509984T3 (lt)
ES (1) ES2118719T3 (lt)
FI (1) FI101399B1 (lt)
HK (1) HK1007456A1 (lt)
HU (1) HU214509B (lt)
LT (1) LT3422B (lt)
LV (1) LV10119B (lt)
MC (2) MC2243A1 (lt)
NO (1) NO302484B1 (lt)
OA (1) OA09706A (lt)
RO (1) RO114805B1 (lt)
SG (1) SG49871A1 (lt)
WO (1) WO1991010731A1 (lt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL173978B1 (pl) * 1992-07-13 1998-05-29 Nika Health Products Ltd Sposób oddziaływania na wydzielanie cytokin w hodowli limfocytów krwi obwodowej
US6183742B1 (en) 1992-07-13 2001-02-06 Nika Health Products, Limited Applications of lysozyme dimer
DZ1964A1 (fr) * 1995-01-13 2002-10-15 Nika Health Products Ltd Nouvelle applications d'un dimère de lysozyme.
US6123937A (en) * 1997-03-14 2000-09-26 Nika Health Products, Limited Applications of lysozyme dimer
US7348301B2 (en) * 2006-02-16 2008-03-25 Buckman Laboratories International, Inc. Lysozyme-based method and composition to control the growth of microorganisms in aqueous systems
US9279118B2 (en) * 2011-10-05 2016-03-08 The Rockefeller University Dimeric bacteriophage lysins
CN111751468A (zh) * 2020-07-03 2020-10-09 上海艾魁英生物科技有限公司 溶菌酶二聚体的纯化及其标准品制备的方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7850731B2 (en) 2006-10-04 2010-12-14 Seaspine, Inc. Articulating spinal implant

Also Published As

Publication number Publication date
KR0158216B1 (ko) 1998-11-16
JP2732514B2 (ja) 1998-03-30
CA2073351C (en) 2001-10-16
EP0509984B1 (en) 1998-06-03
LT3422B (en) 1995-09-25
RO114805B1 (ro) 1999-07-30
NO302484B1 (no) 1998-03-09
BR9007971A (pt) 1992-11-17
LV10119B (en) 1995-02-20
BG96578A (bg) 1993-12-24
HU9202250D0 (en) 1992-10-28
NO922626L (no) 1992-09-07
HUT65931A (en) 1994-07-28
WO1991010731A1 (en) 1991-07-25
DE69032375T2 (de) 1998-11-19
LV10119A (lv) 1994-05-10
HU214509B (hu) 1998-03-30
MC2242A1 (fr) 1993-02-23
CA2073351A1 (en) 1991-07-09
LTIP594A (en) 1994-12-27
AU654651B2 (en) 1994-11-17
NO922626D0 (no) 1992-07-03
SG49871A1 (en) 1998-06-15
EP0509984A1 (en) 1992-10-28
ES2118719T3 (es) 1998-10-01
JPH05505092A (ja) 1993-08-05
DK0509984T3 (da) 1999-03-22
MC2243A1 (fr) 1993-02-23
OA09706A (en) 1993-08-30
FI923123A (fi) 1992-07-07
FI923123A0 (fi) 1992-07-07
DE69032375D1 (de) 1998-07-09
HK1007456A1 (en) 1999-04-09
FI101399B (fi) 1998-06-15
FI101399B1 (fi) 1998-06-15
AU4847490A (en) 1991-08-05

Similar Documents

Publication Publication Date Title
EP0144019A2 (en) Ultrapure hyaluronic acid and method of making it
McAllister et al. The isomaltulose synthesising enzyme of Serratia plymuthica
Van Heyningen Fluorescent derivatives of 3-hydroxy-L-kynurenine in the lens of man, the baboon and the grey squirrel.
BG61040B1 (bg) Метод за получаване на пречистени лизозимни димери
EP1132469A2 (en) Methods for separating nucleic acids from Protein-nucleic acids complexes
EP0143393A2 (en) The use of ultrapure hyaluronic acid to improve animal joint function
Phillips et al. Techniques for the fractionation of microbiologically active peptides derived from casein
Sarngadharan et al. Purification of rabbit liver fructose 1, 6-diphosphatase by substrate elution
US5314816A (en) Method of preparing lysozyme dimers
Bas et al. Purification and properties of staphylocoagulase
US6316236B1 (en) Lysozyme dimer
RU2067617C1 (ru) Способ получения димера лизоцима
NZ208241A (en) Purification of blood plasma or serum: selective removal of (very) low density lipoproteins (ldl and vldl)
CA1334390C (en) Glycoprotein growth modulation materials
Rottem et al. Cerulenin‐Induced Changes in the Lipopolysaccharide Content and Phospholipid Composition of Proteus mirabilis
SU1655987A1 (ru) Способ получени очищенной нейраминидазы холерного вибриона
König et al. Effect of Pseudomonas aeruginosa Alginate on Escherichia coli-and Staphylococcus aureus-lnduced Inflammatory Mediator Release from Human Cells
SU1629316A1 (ru) Способ выделени пероксидазы из культурального фильтрата базидиального гриба CeRReNa махIма MURR
CA2073350C (en) Ribonuclease dimers and method of preparing them
JPH0725798B2 (ja) ＴＧＦ−β制御糖タンパク質
Nikolaev Chromatography of proteins on cellulose ion exchangers
JPS6251592B2 (lt)
JPH03280899A (ja) 酵素活性の測定方法